CC
ZBH icon

Cedar Capital’s Zimmer Biomet ZBH Stock Holding History

Cedar Capital’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,136
Closed -$547K – 178
2020
Q3 		$547K Buy
4,136
+1,345
+48% +$176K 0.18% 121
2020
Q2 		$323K Buy
2,791
+158
+6% +$18.2K 0.12% 144
2020
Q1 		$258K Sell
2,633
-64
-2% -$8.39K 0.12% 135
2019
Q4 		$392K Buy
2,697
+571
+27% +$78.8K 0.18% 133
2019
Q3 		$283K Buy
+2,126
New +$275K 0.13% 145
2019
Q2 		– Sell
-1,829
Closed -$227K – 168
2019
Q1 		$227K Buy
+1,829
New +$208K 0.1% 150
2018
Q4 		– Sell
-2,436
Closed -$311K – 177
2018
Q3 		$311K Buy
+2,436
New +$290K 0.12% 145

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Cedar Capital's ZBH Position: Q4 2020 in Review

Cedar Capital sold out of Zimmer Biomet (ZBH) in Q4 2020, closing a stake of 4,136 shares — an estimated $547K sold.

Cedar Capital first reported a position in ZBH in Q3 2018 and held it in 7 quarters. The position peaked at $547K in Q3 2020. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q4 2020.

  • Cedar Capital reported no remaining Zimmer Biomet position as of Q4 2020 after selling out during the quarter.
  • Cedar Capital sold 4,136 Zimmer Biomet shares in Q4 2020, an estimated $547K.
  • Cedar Capital first reported a position in Zimmer Biomet in Q3 2018 and held it in 7 quarters.
  • Cedar Capital's Zimmer Biomet position peaked at $547K in Q3 2020.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2020.

Based on Cedar Capital's 13F filing for Q4 2020, filed 5 Feb 2021.